GB:0P40's free cash flow for Q2 2022 was €―. For the 2022 fiscal year, GB:0P40's free cash flow was decreased by €-3.77M and operating cash flow was €―. See a summary of the company’s cash flow.

Cash Flow	TTM	Dec 20	Dec 19	Dec 18	Dec 17	Dec 16
Operating Cash Flow	-	€ -2.64M	€ 1.24M	€ 34.00K	€ -1.68M	€ -1.53M
Investing Cash Flow	-	€ 329.00K	€ 161.00K	€ -397.00K	€ -1.42M	€ -3.08M
Financing Cash Flow	-	€ 2.26M	€ -1.74M	€ 263.00K	€ 228.00K	€ 6.63M
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	-	€ 141.00K	€ 191.00K	€ 530.00K	€ 630.00K	€ 3.50M
Income Tax Paid Supplemental Data	-	-	-	-	-	-
Interest Paid Supplemental Data	-	-	-	-	-	-
Issuance Of Capital Stock	-	€ 1.88M	€ 288.00K	€ 1.35M	€ 0.00	-
Issuance Of Debt	-	€ 1.54M	€ 3.07M	€ 2.61M	€ 3.04M	€ 2.10M
Repayment Of Debt	-	€ -922.00K	€ -2.20M	€ -3.32M	€ -2.07M	€ -187.00K
Free Cash Flow	-	€ -2.67M	€ 1.10M	€ -481.00K	€ -2.45M	€ -2.61M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in EUR

Bioera SpA Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing